Organoid Cultures Derived from Patients with Advanced Prostate Cancer

Gao, Dong, Vela, Ian, Sboner, Andrea, Iaquinta, Phillip J., Karthaus, Wouter R., Gopalan, Anuradha, Dowling, Catherine, Wanjala, Jackline N. +31 more·2014·Cell
DOI 10.1016/j.cell.2014.08.016

Cited by (1,000)

Items 801–900 of 1,000

  1. Pancreatic Cancer Organoids in the Field of Precision Medicine: A Review of Literature and Experience on Drug Sensitivity Testing with Multiple Readouts and Synergy Scoring
    Lotta Mäkinen, Markus J. V. Vähä-Koskela, Matilda Juusola, Harri K. Mustonen, Krister Wennerberg, Jaana Hagström, Pauli Antero Puolakkainen, Hanna E. Seppänen · 2022 · Cancers
  2. FOXA1 can be modulated by HDAC3 in the progression of epithelial ovarian carcinoma
    Tong Lou, Chongdong Liu, Hong Qu, Zhiqiang Zhang, Shuzhen Wang, Huiyu Zhuang · 2022 · Journal of Translational Medicine
  3. Investigating Cutaneous Squamous Cell Carcinoma in vitro and in vivo: Novel 3D Tools and Animal Models
    Marika Quadri, Alessandra Marconi, Simran Kaur Sandhu, Alexi Kiss, Tatiana Efimova, Elisabetta Palazzo · 2022 · Frontiers in Medicine
  4. Global Trends of Stem Cell Precision Medicine Research (2018–2022): A Bibliometric Analysis
    Muge Liu, Fan Yang, Yingbin Xu · 2022 · Frontiers in Surgery
  5. Development of bioinformatics and multi-omics analyses in organoids
    Doyeon Ha, JungHo Kong, Donghyo Kim, Kwanghwan Lee, Juhun Lee, Minhyuk Park, Hyunsoo Ahn, Youngchul Oh, Sanguk Kim · 2022 · BMB Reports
  6. Establishment of an organoid bank of biliary tract and pancreatic cancers and its application for personalized therapy and future treatment
    Yoshimasa Saito · 2019 · Journal of Gastroenterology and Hepatology
  7. Reproduction of the Antitumor Effect of Cisplatin and Cetuximab Using a Three-dimensional Spheroid Model in Oral Cancer
    Kisho Ono, Kohei Sato, Tomoya Nakamura, Yume Yoshida, Shogo Murata, Kunihiro Yoshida, Hideka Kanemoto, Koki Umemori, Hotaka Kawai, Kyoichi Obata et al. · 2022 · International Journal of Medical Sciences
  8. ALDH1A3 serves as a predictor for castration resistance in prostate cancer patients
    Shangqian Wang, Xiang Zhou, Chao Liang, Meiling Bao, Ye Tian, Jundong Zhu, Tongtong Zhang, Jie Yang, Zengjun Wang · 2020 · BMC Cancer
  9. A PSA SNP associates with cellular function and clinical outcome in men with prostate cancer
    Srilakshmi Srinivasan, Thomas Kryza, Nathalie Bock, Brian Wan-Chi Tse, Kamil A. Sokolowski, Janaththani Panchadsaram, Achala Fernando, Leire Moya, Carson Ryan Stephens, Ying Dong et al. · 2024 · Nature Communications
  10. Fibronectin Regulation of Integrin B1 and SLUG in Circulating Tumor Cells
    Jeannette Huaman, Michelle K. Naidoo, Xingxing Zang, Olorunseun Olatunji Ogunwobi · 2019 · Cells
  11. Circulating Tumor Cell Migration Requires Fibronectin Acting through Integrin B1 or SLUG
    Jeannette Huaman, Olorunseun Olatunji Ogunwobi · 2020 · Cells
  12. Material properties of disulfide-crosslinked hyaluronic acid hydrogels influence prostate cancer cell growth and metabolism
    Nicky W. Tam, Dudley Chung, Samuel J. Baldwin, Jeffrey R. Simmons, Lingling Xu, Jan K. Rainey, Graham Dellaire, John P. Frampton · 2020 · Journal of Materials Chemistry B
  13. Preclinical tumor organoid models in personalized cancer therapy: Not everyone fits the mold
    Lifeng Hu, Xue Yang, Huanrong Lan, Xingliang Fang, Xiaoyi Chen, Ketao Jin · 2021 · Experimental Cell Research
  14. Application of Patient-Derived Cancer Organoids to Personalized Medicine
    Masahiro Shiihara, Toru Furukawa · 2022 · Journal of Personalized Medicine
  15. A brief history of testicular organoids: from theory to the wards
    Nengzhuang Wang, Shen Jiaming, L. I. U. Minghua, Long Ma, Q. I. N. Lina, G. E. Xuemei, Y. A. N. Hongli · 2022 · Journal of Assisted Reproduction and Genetics
  16. CCT251545 enhances drug delivery and potentiates chemotherapy in multidrug-resistant cancers by Rac1-mediated macropinocytosis
    Siyuan Qin, Zhe Zhang, Zhao Huang, Yinheng Luo, Ningna Weng, Bowen Li, Yongquan Tang, Li Zhou, Jingwen Jiang, Yi Lü et al. · 2022 · Drug Resistance Updates
  17. Preclinical models to study patient-derived circulating tumor cells and metastasis
    Kanve Nagaraj Suvilesh, Yariswamy Manjunath, Klaus Pantel, Jussuf T. Kaifi · 2023 · Trends in cancer
  18. Single-cell omics: a new perspective for early detection of pancreatic cancer?
    Qi Wang, Berina Šabanović, Azhar Awada, Chiara Reina, Alexandra Aicher, Jiajia Tang, Christopher Heeschen · 2023 · European Journal of Cancer
  19. Organoids in ovarian cancer: a platform for disease modeling, precision medicine, and drug assessment
    Haiyao Hu, Chongen Sun, Jingyao Chen, Zhengyu Li · 2024 · Journal of Cancer Research and Clinical Oncology
  20. PAX6 promotes neuroendocrine phenotypes of prostate cancer via enhancing MET/STAT5A-mediated chromatin accessibility
    Nan Jing, Xinxing Du, Liang Yu, Zhenkeke Tao, Shijia Bao, Huixiang Xiao, Baijun Dong, Wei‐Qiang Gao, Yuxiang Fang · 2024 · Journal of Experimental & Clinical Cancer Research
  21. SIRPB1 promotes prostate cancer cell proliferation via Akt activation
    Qiong Song, Siyuan Qin, Laura E. Pascal, Chunlin Zou, Wenchu Wang, Haibo Tong, Jian Zhang, William J. Catàlona, Rajiv Dhir, Megan Morrell et al. · 2020 · The Prostate
  22. Insights into brain metastasis: Recent advances in circulating tumor cell research
    Remi V. Klotz, Min Yu · 2020 · Cancer Reports
  23. Pleiotropic Mechanisms Drive Endocrine Resistance in the Three-Dimensional Bone Microenvironment
    Eugen Dhimolea, Ricardo De Matos Simoes, Dhvanir N. Kansara, Xiang Weng, Shruti Sharma, Pallavi Awate, Zhiyi Liu, Dong Gao, Nicholas Mitsiades, Joseph Hasbrouck Schwab et al. · 2020 · Cancer Research
  24. The Roles of SPOP in DNA Damage Response and DNA Replication
    Masashi Maekawa, Shigeki Higashiyama · 2020 · International Journal of Molecular Sciences
  25. Construction of in vitro patient‑derived tumor models to evaluate anticancer agents and cancer immunotherapy
    Nobuhiko Takahashi, Arisa Higa, Gen Hiyama, Hirosumi Tamura, Hirotaka Hoshi, Yuu Dobashi, Kiyoaki Katahira, Hiroya Ishihara, Kosuke Takagi, Kazuhito Goda et al. · 2021 · Oncology Letters
  26. A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer
    Volga M Saini, Ezgi Öner, Mark P. Ward, Sinead M. Hurley, Brian David Henderson, Faye Lewis, Stephen P. Finn, Gerard J. Fitzmaurice, John J. O’Leary, Sharon A. O’Toole et al. · 2024 · Molecular Oncology
  27. Patient-derived organoid co-culture systems as next-generation models for bladder cancer stem cell research
    Ruici Yang, Shanzhao Wang, Zhichao Li, Cong Yin, Wei Huang, Weiren Huang · 2025 · Cancer Letters
  28. Clinical Application of Circulating Tumour Cells in Prostate Cancer: From Bench to Bedside and Back
    Luis León‐Mateos, María Vieito, Urbano Anido, Rafael López‐López, Laura Muinelo‐Romay · 2016 · International Journal of Molecular Sciences
  29. The Promise of Circulating Tumor Cells for Precision Cancer Therapy
    William L. Hwang, Katie L. Hwang, David Tomoaki Miyamoto · 2016 · Biomarkers in Medicine
  30. Organoids as research models for hepatocellular carcinoma
    Justin HY. Yu, Stephanie Ma · 2021 · Experimental Cell Research
  31. Prostate organogenesis
    Andrew Pletcher, Maho Shibata · 2022 · Development
  32. The future of patient-derived xenografts in prostate cancer research
    Mitchell G. Lawrence, Renea A. Taylor, Georgia B. Cuffe, Lisa S. Ang, Ashlee K. Clark, David L. Goode, Laura H. Porter, Clémentine Le Magnen, Nora Maria Navone, Jack A. Schalken et al. · 2023 · Nature Reviews Urology
  33. Breast cancer patient-derived explant cultures recapitulate in vivo drug responses
    Solveig Pettersen, Geir Frode Øy, Eivind Valen Egeland, Siri Juell, Olav Engebråten, Gunhild Mari Mælandsmo, Lina Prasmickaite · 2023 · Frontiers in Oncology
  34. Preclinical Models of Neuroendocrine Prostate Cancer
    Alessia Cacciatore, Domenico Albino, Carlo Vittorio Catapano, Giuseppina Maria Carbone · 2023 · Current Protocols
  35. Organoids derived from patients provide a new opportunity for research and individualized treatment of malignant peritoneal mesothelioma
    Xiao-chang Fang, Lin Shu, TianLiang Chen, XiaoLe Zhao, LiuCui Yang, Tingting Dou, Lijie Yang, Xuanfei Li, Maohui Feng · 2024 · Molecular Cancer
  36. Graphene Oxide Nanoparticles and Organoids: A Prospective Advanced Model for Pancreatic Cancer Research
    Shaoshan Mai, Iwona Inkielewicz‐Stępniak · 2024 · International Journal of Molecular Sciences
  37. A miniaturized optical tomography platform for volumetric imaging of engineered living systems
    Adem Polat, Shabir Hassan, İsa Yıldırım, Luis Eduardo Oliver, Maryam Mostafaei, Siddharth Kumar, Sushila Maharjan, Louis Bourguet, Xia Cao, Guoliang Ying et al. · 2019 · Lab on a Chip
  38. Preclinical Modelling of PDA: Is Organoid the New Black?
    Sabrina L. D’Agosto, Silvia Andreani, Aldo Scarpa, Vincenzo Corbo · 2019 · International Journal of Molecular Sciences
  39. Organotypic Modeling of the Tumor Landscape
    Maria M. Haykal, Clara Nahmias, Christine Varon, Océane C. B. Martin · 2020 · Frontiers in Cell and Developmental Biology
  40. Organoid Models for Cancer Research—From Bed to Bench Side and Back
    Carolin Kastner, Anne Hendricks, Hanna Deinlein, Mohammed K. Hankir, Christoph‐Thomas Germer, Stefanie Schmidt, Armin Wiegering · 2021 · Cancers
  41. Leukemia inhibitory factor receptor homodimerization mediated by acetylation of extracellular lysine promotes prostate cancer progression through the PDPK1/AKT/GCN5 axis
    Yufeng Ding, Honggang Chi, Jialiang Shao, Tiezhu Shi, Hua Tao Yu, Xiang Wang, Xiongjun Wang · 2022 · Clinical and Translational Medicine
  42. Personalizing pancreatic cancer organoids with hPSCs
    Haiyu Zhang, Calvin Jay Kuo · 2015 · Nature Medicine
  43. Conditional reprogramming: Modeling urological cancer and translation to clinics
    Wei Liu, Lingao Ju, Songtao Cheng, Gang Wang, Kaiyu Qian, Xuefeng Liu, Yu Xiao, Xinghuan Wang · 2020 · Clinical and Translational Medicine
  44. A breast cancer patient-derived xenograft and organoid platform for drug discovery and precision oncology
    Katrin P. Guillen, Maihi Fujita, Andrew J. Butterfield, Sandra D. Scherer, Matthew H. Bailey, Zhengtao Chu, Yoko S. DeRose, Ling Zhao, Emilio Cortes-Sanchez, Chieh‐Hsiang Yang et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  45. The challenge of making the right choice: patient avatars in the era of cancer immunotherapies
    Charlotte Kayser, Annika Bräuer, Sebens Susanne, Anna Maxi Wandmacher · 2023 · Frontiers in Immunology
  46. Targeting the histone reader ZMYND8 inhibits antiandrogen-induced neuroendocrine tumor transdifferentiation of prostate cancer
    Hanling Wang, Sulin Zhang, Qiang Pan‐Hammarström, Jiacheng Guo, Li Ni, Lifan Chen, Jun‐Yu Xu, Jingyi Zhou, Yongqiang Gu, Xuege Wang et al. · 2025 · Nature Cancer
  47. An organoid library unveils subtype-specific IGF-1 dependency via a YAP–AP1 axis in human small cell lung cancer
    Takahiro Fukushima, Kazuhiro Togasaki, Junko Hamamoto, Katsura Emoto, Toshiki Ebisudani, Akifumi Mitsuishi, Kai Sugihara, Taro Shinozaki, Masahiko Okada, Ayaka Saito et al. · 2025 · Nature Cancer
  48. Cluster microRNAs miR‐194 and miR‐215 suppress the tumorigenicity of intestinal tumor organoids
    Toshiaki Nakaoka, Yoshimasa Saito, Yuriko Shimamoto, Toshihide Muramatsu, Masaki Kimura, Yae Kanai, Hidetsugu Saito · 2017 · Cancer Science
  49. The power and the promise of organoid models for cancer precision medicine with next-generation functional diagnostics and pharmaceutical exploitation
    Yu‐Shui Ma, Xiao‐Li Yang, Rui Xin, Ting‐Miao Wu, Yi Shi, Dan Dan Zhang, Huimin Wang, Pei‐Yao Wang, Jibin Liu, Da Fu · 2021 · Translational Oncology
  50. A germline SNP in BRMS1 predisposes patients with lung adenocarcinoma to metastasis and can be ameliorated by targeting c-fos
    Yuan Liu, Neel P. Chudgar, Brooke Mastrogiacomo, Di He, Manendra B. Lankadasari, Samhita Bapat, Gregory D. Jones, Francisco Sánchez-Vega, Kay See Tan, Nikolaus D. Schultz et al. · 2022 · Science Translational Medicine
  51. Advances in Tumor Organoids for the Evaluation of Drugs: A Bibliographic Review
    Maritza Londoño-Berrío, Cristina Isabel Castro, Ana Isabel Cañas, Isabel Ortiz, Marlon Osorio · 2022 · Pharmaceutics
  52. Efficient Establishment of Bile-Derived Organoids From Biliary Cancer Patients
    Keisuke Kinoshita, Yoshiyuki Tsukamoto, Yuka Hirashita, Takafumi Fuchino, Shusaku Kurogi, Tomohisa Uchida, Chisato Nakada, Takashi Matsumoto, Kazuhisa Okamoto, Mitsuteru Motomura et al. · 2023 · Laboratory Investigation
  53. Microfluidics and Organoids, the Power Couple of Developmental Biology and Oncology Studies
    Laura Ann Hetzel, Ahmed Ali, Vincenzo Corbo, Thomas Hankemeier · 2023 · International Journal of Molecular Sciences
  54. Engineering prostate cancer in vitro: what does it take?
    Adriana Buskin, Emma Scott, Ryan Nelson, Luke Gaughan, Craig N. Robson, Rakesh Heer, Anastasia C. Hepburn · 2023 · Oncogene
  55. A new scaffold-free tumoroid model provides a robust preclinical tool to investigate invasion and drug response in Renal Cell Carcinoma
    Irinka Séraudie, Catherine Pillet, Beatrice Cesana, Pauline Bazelle, Florian Jeanneret, Bertrand Evrard, Frédéric Chalmel, Assilah Bouzit, Christophe Battail, Jean‐Alexandre Long et al. · 2023 · Cell Death and Disease
  56. Anaplastic thyroid cancer spheroids as preclinical models to test therapeutics
    Jiangnan Hu, Kai‐Li Liu, Chandrayee Ghosh, Tejinder Pal Khaket, Helen Alice Shih, Electron Kebebew · 2024 · Journal of Experimental & Clinical Cancer Research
  57. Sialylation facilitates self-assembly of 3D multicellular prostaspheres by using cyclo-RGDfK(TPP) peptide
    Sabah Haq, Vanessa Samuel, Fiona Haxho, Roman Akasov, Maria V. Leko, Sergey V. Burov, Марквичева Елена Арнольдовна, Myron R. Szewczuk · 2017 · OncoTargets and Therapy
  58. Establishment and Analysis of Three-Dimensional (3D) Organoids Derived from Patient Prostate Cancer Bone Metastasis Specimens and their Xenografts
    Sanghee Lee, Danielle N. Burner, Theresa R. Mendoza, Michelle T. Muldong, Catalina Arreola, Christina N. Wu, Nicholas A. Cacalano, Anna Kulidjian, Christopher J. Kane, Christina A. M. Jamieson · 2020 · Journal of Visualized Experiments
  59. Pathology of circulating tumor cells and the available capture tools (Review)
    Yibing Guan, Fangshi Xu, Juanhua Tian, Hongwei Chen, Chuance Yang, Shanlong Huang, Ke Gao, Ziyan Wan, Mingrui Li, Minxin He et al. · 2020 · Oncology Reports
  60. The Changing Face of in vitro Culture Models for Thyroid Cancer Research: A Systematic Literature Review
    Dylan Chew, Victoria Green, Andrew Riley, Richard James England, John Greenman · 2020 · Frontiers in Surgery
  61. Harnessing the Heterogeneity of Prostate Cancer for Target Discovery Using Patient-Derived Explants
    Margaret M. Centenera, Andrew D. Vincent, Max V. Moldovan, Hui‐Ming Lin, David John Lynn, Lisa Glen Horvath, Lisa M. Butler · 2022 · Cancers
  62. In vitro cultures of circulating tumor cells: a potential tool to unravel drug sensitivity
    Gianluigi De Renzi, Giulia De Marco, Michela De Meo, Eleonora Del Rosso, Paola Gazzaniga, Chiara Nicolazzo · 2022 · Cancer Drug Resistance
  63. Establishment of organoid models based on a nested array chip for fast and reproducible drug testing in colorectal cancer therapy
    Yancheng Cui, Rongrong Xiao, Yushi Zhou, Jianchuang Liu, Yi Wang, Xiaodong Yang, Zhanlong Shen, Bin Liang, Kai Shen, Yi Li et al. · 2022 · Bio-Design and Manufacturing
  64. Evolution of precision oncology‐guided treatment paradigms
    Ramanuj DasGupta, Aixin Yap, Elena Yaqing Yong, Shumei Chia · 2022 · WIREs Mechanisms of Disease
  65. Integrating Microfabrication into Biological Investigations: the Benefits of Interdisciplinarity
    Gianluca Grenci, Cristina Bertocchi, Andrea Ravasio · 2019 · Micromachines
  66. An organoids biobank for recapitulating tumor heterogeneity and personalized medicine
    Hui Yang, Ning Zhang, Yucun Liu · 2020 · Chinese Journal of Cancer Research
  67. Organoids as a new approach for improving pediatric cancer research
    Silvia Lampis, Angela Galardi, Virginia Di Paolo, Angela Di Giannatale · 2024 · Frontiers in Oncology
  68. Comparative analysis of tongue cancer organoids among patients identifies the heritable nature of minimal residual disease
    Miwako Sase, Taku Sato, Hajime Sato, Fuyuki Miya, Shicheng Zhang, Hiroshi Haeno, Mihoko Kajita, Tadahide Noguchi, Yoshiyuki Mori, Toshiaki Ohteki · 2024 · Developmental Cell
  69. Generation of patient-derived sarcoma organoids for personalized drug screening and precision cancer immunotherapy
    Haixia Ma, Xiaoyang Li, Jinxi Li, Jie Bu, Xianan Li, Jie Zhang, Shengji Yu, Guangjun Nie, Hai Wang, Helin Feng · 2025 · Biomaterials
  70. Engineered tumor microspheres via microfluidics and decellularized extracellular matrix for high-throughput organoid-based drug screening
    Jinlong Jin, Wei Chen, Jing Li, Jiahuan Yang, Rui Dai, Junjie Tang, Meiqi Li, You Chen, Changhua Zhang, Jie Liu · 2025 · Biofabrication
  71. Patient-derived organoids as a model for tumor research
    Jia Wang, Xiaoying Feng, Zhichao Li, Yongsong Chen, Weiren Huang · 2022 · Progress in molecular biology and translational science
  72. Transcriptomic Signature and Growth Factor Regulation of Castration-Tolerant Prostate Luminal Progenitor Cells
    Manon Baurès, Emilia Puig Lombardi, Delphine Di Martino, Wail Zeitouni, Emeline Pacreau, Leïla Dos Santos, Charles Dariane, Florence Boutillon, Jacques‐Emmanuel Guidotti, Vincent Goffin · 2022 · Cancers
  73. Tumor Organoids as a Research Tool: How to Exploit Them
    Tijmen H. Booij, Chiara M. Cattaneo, Christian Hirt · 2022 · Cells
  74. Patient-Derived Xenografts and Organoids Recapitulate Castration-Resistant Prostate Cancer with Sustained Androgen Receptor Signaling
    Annelies Van Hemelryk, Ingrid Tomljanović, Corrina M. A. de Ridder, Debra C. Stuurman, Wilma J. Teubel, Sigrun Erkens‐Schulze, Esther I. Verhoef, Sebastiaan Remmers, Amrish J. Mahes, Geert J.L.H. van Leenders et al. · 2022 · Cells
  75. Propagated Circulating Tumor Cells Uncover the Potential Role of NFκB, EMT, and TGFβ Signaling Pathways and COP1 in Metastasis
    Jerry Xiao, Utsav Sharma, Abolfazl Arab, Sohit Miglani, Sonakshi Bhalla, Shravanthy Suguru, Robert K. Suter, Reetu Mukherji, Marc E. Lippman, Paula Raffin Pohlmann et al. · 2023 · Cancers
  76. Clinical utility of emerging liquid biomarkers in advanced prostate cancer
    Gillian Rae Vandekerkhove, Kim N. Chi, Alexander William Wyatt · 2017 · Cancer Genetics
  77. Transcriptional Reprogramming and Novel Therapeutic Approaches for Targeting Prostate Cancer Stem Cells
    Gianluca Civenni, Domenico Albino, Dheeraj A. Shinde, Ramiro Vázquez, Jessica Merulla, Aleksandra Kokanovic, Sarah N. Mapelli, Giuseppina Maria Carbone, Carlo Vittorio Catapano · 2019 · Frontiers in Oncology
  78. The potential and challenges of patient-derived organoids in guiding the multimodality treatment of upper gastrointestinal malignancies
    Georg A. Busslinger, Fianne Lissendorp, Ingrid A. Franken, Richard van Hillegersberg, Jelle P. H. Ruurda, Hans C. Clevers, Michiel F.G. de Maat · 2020 · Open Biology
  79. Current experimental human tissue‐derived models for prostate cancer research
    Manabu Kato, Takeshi Sasaki, Takahiro Inoue · 2020 · International Journal of Urology
  80. Phenotypic characterization of two novel cell line models of castration‐resistant prostate cancer
    Michael C. Haffner, Akshay Bhamidipati, Harrison Kwei Tsai, David Esopi, Ajay M. Vaghasia, Jin‐Yih Low, Radhika A. Patel, Güneş Güner, Minh‐Tam Pham, Nicole Castagna et al. · 2021 · The Prostate
  81. AR-negative prostate cancer is vulnerable to loss of JMJD1C demethylase
    Yohei Yoshihama, Kyle A. LaBella, Eiru Kim, Lori L. Bertolet, Medina Colic, Jiexi Li, Xiaoying Shang, Chang‐Jiun Wu, Denise J. Spring, Yanru Wang et al. · 2021 · Proceedings of the National Academy of Sciences
  82. Use of conditional reprogramming cell, patient derived xenograft and organoid for drug screening for individualized prostate cancer therapy: Current and future perspectives (Review)
    Jessica Cao, Wing Hei Chan, Moses Chow · 2022 · International Journal of Oncology
  83. Circulating Tumor Cells: A Window to Understand Cancer Metastasis, Monitor and Fight Against Cancers
    Lei Xu, Jonathan Shamash, Yong‐Jie Lu · 2015 · Journal of cancer research updates
  84. Stem cells in genetically-engineered mouse models of prostate cancer
    Maho Shibata, Michael M. Shen · 2015 · Endocrine Related Cancer
  85. Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
    Lisa Mohr, Marc Carceles‐Cordon, JungReem Woo, Carlos Cordon‐Cardo, Josep M. Domingo Domenech, Verónica Rodríguez-Bravo · 2017 · Journal of Visualized Experiments
  86. What Role could Organoids Play in the Personalization of Cancer Treatment?
    Hayley E. Francies, Mathew J. Garnett · 2015 · Pharmacogenomics
  87. Generation of prostate cancer assembloids modeling the patient-specific tumor microenvironment
    J.-H. Lee, Yun‐Hee Kim, Cheolmin Matthew Lee, Seong Soo Jeon, H.K. Seo, Jong Won Lee, Jungmin Choi, Minyong Kang, Eunjee Kim, Kunyoo Shin · 2025 · PLoS Genetics
  88. Crosstalk between EZH2 and DNA methylation mediates neuroendocrine prostate cancer lineage plasticity
    Richa Singh, Varadha Balaji Venkadakrishnan, Eddie L. Imada, Yasutaka Yamada, Nicholas J. Brady, Kate E. Dunmore, Richard Garner, Matthew Aaron Booker, Brian P. Hanratty, Michael C. Haffner et al. · 2026 · Nature Communications
  89. The MEMIC is an ex vivo system to model the complexity of the tumor microenvironment
    Libuše Janská, Libi Anandi V, Nell C. Kirchberger, Zoran S. Marinkovic, Logan T. Schachtner, Gizem Guzelsoy, Carlos Carmona‐Fontaine · 2021 · Disease Models & Mechanisms
  90. Current Status of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: A Review
    Sharmin Aktar, Hooman Baghaie, Farhadul Islam, Vinod Gopalan, Alfred King-yin Lam · 2023 · Otolaryngology
  91. Co‐targeting BET , CBP , and p300 inhibits neuroendocrine signalling in androgen receptor‐null prostate cancer
    Nicholas Choo, Shivakumar Keerthikumar, Susanne Ramm, Daisaku Ashikari, Linda Teng, Birunthi Niranjan, Shelley Hedwards, Laura H. Porter, David L. Goode, Kaylene J. Simpson et al. · 2024 · The Journal of Pathology
  92. A Marine Collagen-Based 3D Scaffold for In Vitro Modeling of Human Prostate Cancer Niche and Anti-Cancer Therapeutic Discovery
    Won Hoon Song, Ye Seon Lim, Jieun Kim, Hae Yeong Kang, Chang‐Yong Lee, Lata Rajbongshi, Seon-Yeong Hwang, Sae‐Ock Oh, Byoung Soo Kim, Dongjun Lee et al. · 2024 · Marine Drugs
  93. Organoids in cancer therapies: a comprehensive review
    Jiang Xin-Yi, Wang Yan-Ran, Di Pin-Ru, Qian Shi-Yi, Haitao Jiang · 2025 · Frontiers in Bioengineering and Biotechnology
  94. Biofabrication Technologies for Developing In Vitro Tumor Models
    Andrea R. Mazzocchi, Shay Söker, Aleksander Skardal · 2017 · Cancer drug discovery and develogment/Cancer drug discovery and development
  95. Replacement techniques to reduce animal experiments in drug and nanoparticle development
    Ik Sup Jin, Moon Sup Yoon, Chun‐Woong Park, Jin Tae Hong, Youn Bok Chung, Jinseok Kim, Dae Hwan Shin · 2020 · Journal of Pharmaceutical Investigation
  96. Applications of Omics Technologies for Three-Dimensional In Vitro Disease Models
    Vera M. Pieters, Ileana L. Co, Nila C. Wu, Alison P. McGuigan · 2021 · Tissue Engineering Part C Methods
  97. Biopolymer and Biomaterial Conjugated Iron Oxide Nanomaterials as Prostate Cancer Theranostic Agents: A Comprehensive Review
    Md. Abu Rayhan, Md. Sakib Hossen, Mahruba Sultana Niloy, Mozammel Haque Bhuiyan, Sudip Paul, Md Salman Shakil · 2021 · Symmetry
  98. Genomic Features and Clinical Implications of Intraductal Carcinoma of the Prostate
    Minyong Kang, Hyunwoo Lee, Sun‐ju Byeon, Ghee Young Kwon, Seong Soo Jeon · 2021 · International Journal of Molecular Sciences
  99. Blocking PI3K p110β Attenuates Development of PTEN-Deficient Castration-Resistant Prostate Cancer
    Xueliang Gao, Yubao Wang, Caroline F. Ribeiro, Cherubin Manokaran, Hyeyoun Chang, Thanh Von, Silvia Daniele Rodrigues, Onur Cizmecioglu, Shidong Jia, Manav Korpal et al. · 2022 · Molecular Cancer Research
  100. Instructive Hydrogels for Primary Tumor Cell Culture: Current Status and Outlook
    Yiyang Jia, Zhentong Wei, Songling Zhang, Bai Yang, Yunfeng Li · 2022 · Advanced Healthcare Materials